Vimarsana
Biggest News Aggregation in the World

Page 6 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Heart Today - Breaking & Trending Today

Introducing New York Valves: The Structural Heart Summit - Vimarsana News

Introducing New York Valves: The Structural Heart Summit

The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned a

Introducing New York Valves: The Structural Heart Summit - Vimarsana News

Introducing New York Valves: The Structural Heart Summit

The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned a

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis - Vimarsana News

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

The Evolut FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis - Vimarsana News

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.

Source: yahoo.com
FDA approves next-gen Evolut TAVR system from Medtronic - Vimarsana News

FDA approves next-gen Evolut TAVR system from Medtronic

Medtronic announced that the FDA approved its next-generation Evolut FX+ transcatheter aortic valve replacement (TAVR) system.